II
EBS icon

Inspire Investing’s Emergent Biosolutions EBS Stock Holding History

Inspire Investing’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-42,564
Closed -$313K – 826
2023
Q2 		$313K Buy
42,564
+16,448
+63% +$153K 0.04% 697
2023
Q1 		$271K Buy
26,116
+5,934
+29% +$71.7K 0.03% 757
2022
Q4 		$238K Buy
20,182
+10,356
+105% +$160K 0.03% 370
2022
Q3 		$206K Buy
9,826
+2,712
+38% +$75.5K 0.03% 610
2022
Q2 		$221K Sell
7,114
-15,572
-69% -$532K 0.03% 338
2022
Q1 		$931K Buy
22,686
+17,148
+310% +$756K 0.11% 173
2021
Q4 		$241K Buy
5,538
+1,050
+23% +$47.5K 0.03% 770
2021
Q3 		$225K Buy
+4,488
New +$272K 0.03% 699
2021
Q1 		– Sell
-2,356
Closed -$211K – 640
2020
Q4 		$211K Buy
+2,356
New +$216K 0.05% 602
2020
Q3 		– Sell
-3,410
Closed -$270K – 467
2020
Q2 		$270K Sell
3,410
-824
-19% -$61.4K 0.09% 243
2020
Q1 		$245K Buy
+4,234
New +$244K 0.1% 285

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Inspire Investing's EBS Position: Q3 2023 in Review

Inspire Investing sold out of Emergent Biosolutions (EBS) in Q3 2023, closing a stake of 42,564 shares — an estimated $313K sold.

Inspire Investing first reported a position in EBS in Q1 2020 and held it in 11 quarters. The position peaked at $931K in Q1 2022. 162 funds tracked by Wall St. Rank hold EBS as of Q3 2023.

  • Inspire Investing reported no remaining Emergent Biosolutions position as of Q3 2023 after selling out during the quarter.
  • Inspire Investing sold 42,564 Emergent Biosolutions shares in Q3 2023, an estimated $313K.
  • Inspire Investing first reported a position in Emergent Biosolutions in Q1 2020 and held it in 11 quarters.
  • Inspire Investing's Emergent Biosolutions position peaked at $931K in Q1 2022.
  • 162 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2023.

Based on Inspire Investing's 13F filing for Q3 2023, filed 26 Oct 2023.